SABS
USDSAB Biotherapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$3.140
Hoch
$3.330
Tief
$3.140
Volumen
0.08M
Unternehmensfundamentaldaten
Marktkapitalisierung
33.1M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.27M
Börse
NCM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (NASDAQ:SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other
SAB BIO to Participate in Upcoming Investor Conferences
MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- SAb Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for autoimmune diseases, including its
Ähnliche Aktien
DECA
Denali Capital Acquisition Corp. Ordinary Shares
HE
Hawaiian Electric Industries Inc.
NSSC
NAPCO Security Technologies Inc.
TACT
TransAct Technologies Incorporated
ACRV
Acrivon Therapeutics Inc.
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.